| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adverse event profile for immunotherapy agents compared with chemotherapy in solid organ tumors: a systematic review and meta-analysis of randomized clinical trials
|
Magee, D.E.
|
|
|
31 |
1 |
p. 50-60
|
article
|
| 2 |
Chemotherapy-induced peripheral neuropathy: ice, compression, both, or neither?
|
Loprinzi, C.L.
|
|
|
31 |
1 |
p. 5-6
|
article
|
| 3 |
Cognitive behavioral therapy or graded exercise therapy compared with usual care for severe fatigue in patients with advanced cancer during treatment: a randomized controlled trial
|
Poort, H.
|
|
|
31 |
1 |
p. 115-122
|
article
|
| 4 |
Differential effects of an electronic symptom monitoring intervention based on the age of patients with advanced cancer
|
Nipp, R.D.
|
|
|
31 |
1 |
p. 123-130
|
article
|
| 5 |
Editorial Board
|
|
|
|
31 |
1 |
p. iii
|
article
|
| 6 |
Electronic symptom monitoring: not everyone fits the mold
|
Loh, K.P.
|
|
|
31 |
1 |
p. 13-14
|
article
|
| 7 |
Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma
|
Ugurel, S.
|
|
|
31 |
1 |
p. 144-152
|
article
|
| 8 |
Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges
|
Heil, J.
|
|
|
31 |
1 |
p. 61-71
|
article
|
| 9 |
Financial toxicity in lung cancer: an assessment of magnitude, perception, and impact on quality of life
|
Hazell, S.Z.
|
|
|
31 |
1 |
p. 96-102
|
article
|
| 10 |
Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives
|
Martinelli, E.
|
|
|
31 |
1 |
p. 30-40
|
article
|
| 11 |
Man against machine reloaded: performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions
|
Haenssle, H.A.
|
|
|
31 |
1 |
p. 137-143
|
article
|
| 12 |
Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up ✰
|
Zucca, E.
|
|
|
31 |
1 |
p. 17-29
|
article
|
| 13 |
Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: risk and mortality in The Pooling Project of Prospective Studies of Diet and Cancer
|
Genkinger, J.M.
|
|
|
31 |
1 |
p. 103-114
|
article
|
| 14 |
Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathy ✰
|
Beijers, A.J.M.
|
|
|
31 |
1 |
p. 131-136
|
article
|
| 15 |
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials
|
Yoshino, T.
|
|
|
31 |
1 |
p. 88-95
|
article
|
| 16 |
Obesity, height, and advanced prostate cancer: extending current evidence toward precision prevention
|
Dickerman, B.A.
|
|
|
31 |
1 |
p. 7-8
|
article
|
| 17 |
Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAF v600 mutation–positive melanoma receiving adjuvant vemurafenib
|
Ascierto, P.A.
|
|
|
31 |
1 |
p. 153-159
|
article
|
| 18 |
Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)
|
Kundranda, M.
|
|
|
31 |
1 |
p. 79-87
|
article
|
| 19 |
Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer ✰
|
De Ruysscher, D.
|
|
|
31 |
1 |
p. 41-49
|
article
|
| 20 |
Relation of cetuximab-induced skin toxicity and early tumor shrinkage in metastatic colorectal cancer patients: results of the randomized phase 3 trial FIRE-3 (AIO KRK0306)
|
Holch, J.W.
|
|
|
31 |
1 |
p. 72-78
|
article
|
| 21 |
Should we optimize cytotoxic therapy by dosing to neutropenia? Lessons from TAS-102
|
Kasi, P.M.
|
|
|
31 |
1 |
p. 15-16
|
article
|
| 22 |
Table of Contents
|
|
|
|
31 |
1 |
p. i-ii
|
article
|
| 23 |
Thanks to Referees 2019
|
|
|
|
31 |
1 |
p. 1-4
|
article
|
| 24 |
The challenge of identifying which stage III melanoma patients need adjuvant treatment and with what
|
Nathan, P.
|
|
|
31 |
1 |
p. 11-12
|
article
|
| 25 |
Transferring effective interventions for cancer-related fatigue from the adjuvant to the advanced cancer session: does it work?
|
May, A.M.
|
|
|
31 |
1 |
p. 9-10
|
article
|
Journal description